Matthew J. Pianko

Matthew J. Pianko

Hematology | Oncology
1500 E Medical Center Dr
Floor B1 Reception A
Ann Arbor, MI 48109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma.

Journal: The New England journal of medicine
Published: June 15, 2026

Condensed vs. Standard Step-Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma.

Condensed vs. Standard Step-Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma.

Journal: European journal of haematology
Published: April 02, 2026

Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 23, 2026

Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.

Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.

Journal: American journal of hematology
Published: February 07, 2026

Current experiences with teclistamab in patients with multiple myeloma and renal impairment.

Current experiences with teclistamab in patients with multiple myeloma and renal impairment.

Journal: Expert review of hematology
Published: September 29, 2025

Linvoseltamab in Patients With Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses.

Linvoseltamab in Patients With Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses.

Journal: Clinical lymphoma, myeloma & leukemia
Published: September 23, 2025

Small molecule screening identifies cytotoxic endoplasmic reticulum-associated degradation inhibitors in multiple myeloma.

Small molecule screening identifies cytotoxic endoplasmic reticulum-associated degradation inhibitors in multiple myeloma.

Journal: Cell death & disease
Published: August 06, 2025

Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma.

Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma.

Journal: Future science OA
Published: July 12, 2025

Identification of Omaveloxolone as An Endoplasmic Reticulum Associated Degradation Inhibitor That Induces Early Apoptotic Signaling in Multiple Myeloma.

Identification of Omaveloxolone as An Endoplasmic Reticulum Associated Degradation Inhibitor That Induces Early Apoptotic Signaling in Multiple Myeloma.

Journal: bioRxiv : the preprint server for biology
Published: April 16, 2025

Refining renal response assessment in monoclonal immunoglobulin deposition disease: Challenges, limitations and need for consensus.

Refining renal response assessment in monoclonal immunoglobulin deposition disease: Challenges, limitations and need for consensus.

Journal: Leukemia
Published: March 30, 2025

Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells.

Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 18, 2024

Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practice.

Frailty measures in multiple myeloma: evaluating the impact on outcomes and quality-of-life in clinical trials and real-world practice.

Journal: Leukemia & lymphoma
Published: October 28, 2024
Showing 1-12 of 36

Last Updated: 09/26/2026